Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- LB-100Phase 21 trial
Lixte Biotechnology Holdings, Inc. · Myelodysplastic Syndromes
- LBL-033Phase 21 trial
Nanjing Leads Biolabs Co.,Ltd · Advanced Malignant Tumors
- LBL-034Phase 21 trial
Nanjing Leads Biolabs Co.,Ltd · Relapsed/Refractory Multiple Myeloma
- LBS-007Phase 21 trial
Lin BioScience, Inc · Relapsed or Resistant Acute Leukaemias
- LCB02APhase 21 trial
LigaChem Biosciences, Inc. · Advanced Solid Tumors
- LCB84Phase 21 trial
LigaChem Biosciences, Inc. · Advanced Solid Tumors
- LEO 138559LEO 138559 is also called "temtokibart"Phase 21 trial
LEO Pharma · Atopic Dermatitis
- leronlimabPRO 140Phase 21 trial
CytoDyn, Inc. · Metastatic Colorectal Cancer (mCRC)
- LesigerceptPhase 21 trial
Yuhan Corporation · Allergic Diseases, Chronic Spontaneous Urticaria (CSU)
- Letetresgene autoleucellete-cel, GSK3377794Phase 21 trial
USWM CT, LLC · Neoplasms
- LEU011Phase 21 trial
Leucid Bio · Tumor, Solid
- LG00313112Phase 21 trial
LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer
- LHP588Phase 21 trial
Lighthouse Pharmaceuticals, Inc. · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
- LIB-01Phase 21 trial
Dicot AB · Erectile Dysfunction
- Linperlisib ; RituximabPhase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Relapsed/Refractory Indolent NHL
- LinrodostatBMS-986205Phase 21 trial
Bristol Myers Squibb · Advanced Cancer
- linvemastatFP-020Phase 21 trial
Foresee Pharmaceuticals Co., Ltd. · Asthma (Diagnosis), Pulmonary Function, Moderate-to-Severe Asthma
- LipovirtidePhase 21 trial
Shanxi Kangbao Biological Product Co., Ltd. · HIV
- Liso-celPhase 21 trial
Bristol Myers Squibb · Lymphoma
- LLX-424Phase 21 trial
Lilac Therapeutics, Inc. · Kidney Stones
- LM-2417Phase 21 trial
LaNova Medicines Limited · Advanced Solid Tumor
- LM-350Phase 21 trial
LaNova Medicines Limited · Malignant Tumors
- LM101Phase 21 trial
LaNova Medicines Limited · Malignant Tumors
- LNP1265Phase 21 trial
Regeneron · Hemophilia B
- lonigutamabPhase 21 trial
ACELYRIN Inc. · Thyroid Eye Disease
- LP-184Phase 21 trial
Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM
- LP-98Phase 21 trial
Shanxi Kangbao Biological Product Co., Ltd. · HIV
- LPM6690176Phase 21 trial
Luye Pharma Group Ltd. · Metastatic Colorectal Cancer (mCRC)
- LQ036Phase 21 trial
Shanghai Novamab Biopharmaceuticals Co., Ltd. · Asthma
- LSALT PeptideMetablokPhase 21 trial
Arch Biopartners Inc. · Acute Kidney Injury, Cardiac Surgery
- LSAM-CisplatinPhase 21 trial
NanOlogy, LLC (doing business as Intryx Therapeutics, LLC) · Diffuse Midline Glioma (DMG), Diffuse Intrinsic Pontine Glioma (DIPG), Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
- LTG-001Phase 21 trial
Latigo Biotherapeutics · Acute Pain, Postoperative
- LTI-03Phase 21 trial
Rein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF)
- LTT462Phase 21 trial
Novartis · Melanoma
- LTX-002Phase 21 trial
Leal Therapeutics, Inc · Amyotrophic Lateral Sclerosis
- Lu-177-DGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- lufepirsenNEXAGONPhase 21 trial
Glaukos Corporation · Persistent Corneal Epithelial Defect
- LUM015Phase 21 trial
Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer
- LV232Phase 21 trial
Vigonvita Life Sciences · MDD
- LW231Phase 21 trial
Shanghai Longwood Biopharmaceuticals Co., Ltd. · Chronic HBV Infection
- LXE408Phase 21 trial
Novartis · Chagas Disease
- LY01021Phase 21 trial
Luye Pharma Group Ltd. · Assisted Reproduction
- LY03015LPM3770164 sustained releasePhase 21 trial
Luye Pharma Group Ltd. · Tardive Dyskinesia (TD)
- LY03020Phase 21 trial
Luye Pharma Group Ltd. · Schizophrenia
- LY2784544Phase 21 trial
Eli Lilly · Neoplasms, Hematologic
- LY3457263Phase 21 trial
Eli Lilly · Type 2 Diabetes
- LY3537021Phase 21 trial
Eli Lilly · Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions
- LY3848575Phase 21 trial
Eli Lilly · Neuropathic Pain, Distal Sensory Polyneuropathy
- LY3871801Phase 21 trial
Eli Lilly · Rheumatoid Arthritis
- LY3884961Phase 21 trial
Prevail Therapeutics · Parkinson Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.